{"id":51468,"date":"2024-03-14T13:11:41","date_gmt":"2024-03-14T12:11:41","guid":{"rendered":"https:\/\/quimark.com\/?p=51468"},"modified":"2024-08-09T05:30:30","modified_gmt":"2024-08-09T03:30:30","slug":"endopredict","status":"publish","type":"post","link":"https:\/\/quimark.com\/en\/endopredict\/","title":{"rendered":"EndoPredict\u00ae"},"content":{"rendered":"

[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.24.2\u2033 _module_preset=\u201ddefault\u201d background_color=\u201d#002855\u2033 custom_padding=\u201d6px||6px||true|false\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.24 .2\u2033 _module_preset=\u201ddefault\u201d custom_padding=\u201d15px||9px||false|false\u201d global_colors_info=\u201d{}\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.24.2\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d {}\u201d][et_pb_text _builder_version=\u201d4.27.0\u2033 _module_preset=\u201ddefault\u201d text_font=\u201d|700|||||||\u201d text_text_color=\u201d#FFFFFF\u201d text_font_size=\u201d46px\u201d text_line_height=\u201d1.2em\u201d header_font=\u201d|700|||||||\u201d header_text_color=\u201d#FFFFFF\u201d header_font_size=\u201d46px\u201d header_line_height=\u201d1.2em\u201d background_enable_color=\u201doff\u201d text_orientation=\u201dcenter\u201d width=\u201d66%\u201d module_alignment=\u201dcenter\u201d custom_padding=\u201d42px||18px||false|false\u201d header_font_tablet =\u201d|700|||||||\u201d header_font_phone=\u201d|700|||||||\u201d header_font_last_edited=\u201don|phone\u201d header_font_size_tablet=\u201d46px\u201d header_font_size_phone=\u201d22px\u201d header_font_size_last_edited=\u201don|phone\u201d global_colors_info=\u201d{}\u201d]<\/p>\n

EndoPredict\u00ae<\/span><\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.24.2\u2033 _module_preset=\u201ddefault\u201d custom_padding=\u201d10px||4px|||\u201d global_colors_info=\u201d{}\u201d][et_pb_row column_structure=\u201d1_4,3_4\u2033 _builder_version=\u201d4.27.0\u2033 _module_preset=\u201ddefault\u201d custom_margin=\u201d18px|auto||auto||\u201d custom_padding=\u201d|51px||||\u201d global_colors_info=\u201d{}\u201d][et_pb_column type=\u201d1_4\u2033 _builder_version=\u201d4.27.0\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d][et_pb_image src=\u201dhttps:\/\/quimark.com\/wp-content\/ uploads\/2024\/08\/donna-35-anni-con-medico-in-secondo-piano_WEB-1.jpg\u201d title_text=\u201dwoman 35 years old with doctor in the background_WEB\u201d force_fullwidth=\u201don\u201d _builder_version=\u201d4.27.0\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d][\/et_pb_image][et_pb_image src=\u201dhttps:\/\/quimark.com\/wp-content\/uploads\/2024\/03\/EndoPredict_Color_Italian-1.png\u201d title_text=\u201dEndoPredict_Color_Italian\u201d _builder_version=\u201d4.24.3\u2033 _module_preset=\u201ddefault\u201d width=\u201d100%\u201d global_colors_info =\u201d{}\u201d][\/et_pb_image][\/et_pb_column][et_pb_column type=\u201d3_4\u2033 _builder_version=\u201d4.25.1\u2033 _module_preset=\u201ddefault\u201d global_colors_info=\u201d{}\u201d][et_pb_text _builder_version=\u201d4.27.0\u2033 text_font =\u201d|600|||||||\u201d text_text_color=\u201d#c8102e\u201d text_font_size=\u201d22px\u201d text_line_height=\u201d1.2em\u201d custom_margin=\u201d||-1px|||\u201d custom_padding=\u201d||17px|||\u201d global_colors_info=\u201d{}\u201d]<\/p>\n

Second Generation Genomic Testing for Breast Cancer<\/p>\n

[\/et_pb_text][et_pb_text _builder_version=\u201d4.27.0\u2033 text_font=\u201d||||||||\u201d text_text_color=\u201d#000000\u2033 text_font_size=\u201d17px\u201d text_line_height=\u201d1.8em\u201d ol_line_height=\u201d1.8em\u201d header_3_font=\u201d|700|||||||\u201d header_3_font_size=\u201d23px\u201d header_3_line_height=\u201d1.5em\u201d custom_margin=\u201d-10px|||||\u201d global_colors_info=\u201d{}\u201d]<\/p>\n

<\/h3>\n

EndoPredict Utilities<\/h3>\n

EndoPredict is a prognostic-predictive test for early-stage hormone receptor-positive (ER+\/HER2-) breast cancer.<\/p>\n

EndoPredict has been shown to:<\/p>\n